Trinity Biotech (TRIB) Research & Development (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Research & Development of -$1.5 million for Q4 2024, down 30.08% year-on-year from -$2.1 million in Q1 2024, and down 43.86% on a QoQ basis from -$1.0 million in Q3 2024.
Trinity Biotech (TRIB) Research & Development (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Research & Development for 16 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2024.
- Quarterly Research & Development fell 30.08% year-over-year to -$1.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4.5 million (down 3.75% YoY) and the FY2025 annual result came in at $3.6 million, down 20.12% from the prior year.
- Research & Development fell to -$1.5 million in Q4 2024 per TRIB's latest filing, from -$1.0 million in the prior quarter.
- Over the last five years, Research & Development for TRIB reached as high as -$860000.0 in Q1 2023 and fell as low as -$1.5 million in Q4 2024.
- A 5-year average of -$1.1 million and a median of -$1.1 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 32.85% — and 2024, when it sank 30.08%.
- Year by year, Research & Development stood at -$1.3 million in 2020, then rose by 26.71% to -$941000.0 in 2021, then dropped by 23.91% to -$1.2 million in 2022, then gained by 4.2% to -$1.1 million in 2023, then plunged by 30.08% to -$1.5 million in 2024.
- According to Business Quant data, Research & Development over the past three periods registered -$1.5 million, -$1.0 million, and -$991000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -991,000.00 |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -1.23 Mn |
| Mar 31, 2023 | -860,000.00 |
| Dec 31, 2022 | -1.17 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -984,000.00 |
| Mar 31, 2022 | -965,000.00 |
| Dec 31, 2021 | -941,000.00 |
| Sep 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | -1.44 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Sep 30, 2020 | -1.27 Mn |
| Jun 30, 2020 | -1.15 Mn |
| Mar 31, 2020 | -1.38 Mn |